@entity19547 is a subcutaneous @entity3217 of chronic evolution caused by the Lacazia loboi fungus. Its distribution is almost exclusive in the Americas, and it has a particularly high prevalence in the Amazon basin. Cases of @entity19547 have been reported only in dolphins and @entity1 . Its prevalence is higher among @entity1 who are active in the forest, such as @entity2144 , bushmen, miners, and Indian @entity1 . It is recognized that the traumatic implantation of the fungus on the skin is the route by which @entity1 acquire this infection. The lesions affect mainly exposed areas such as the auricles and upper and lower limbs and are typically presented as @entity75 . Currently, surgical removal is the therapeutic procedure of choice in initial cases. Despite the existing data and studies to date, the active immune mechanisms in this infection and its involvement in the control or development of lacaziosis have not been fully clarified. In recent years, little progress has been made in the appraisal of the epidemiologic aspects of the disease. So far, we have neither a population-based study nor any evaluation directed to the forest workers.

XXXX : epidemiology, clinical presentation, and management options.

@entity19547 :: ('MESH:D060368', 'Disease') :: ['Lobomycosis', 'lobomycosis'] @entity1 :: ('9606', 'Species') :: ['humans', 'men'] @entity3217 :: ('MESH:D015821', 'Disease') :: ['mycosis'] @entity75 :: ('MESH:D001927', 'Disease') :: ['keloid-like lesions'] @entity2144 :: ('MESH:D020315', 'Disease') :: ['rubber tappers']
@entity19547 :: (MESH:D060368,Disease) :: ['Lobomycosis']
